The Cost-Effectiveness of Bendamustine-Rituximab Versus Fludarabine-Rituximab for Patients with Indolent Non-Hodgkin’s Lymphoma (INHL) Who Have Progressed Following Treatment with Rituximab or a Rituximab-Containing Regimen in Colombia
Bertwistle, D, Munakata, J, Wehler, E, Leyva, V, Ariza, J.G, Zambrano, C, Gonzalez, L
Published in Value in health (01.11.2013)
Published in Value in health (01.11.2013)
Get full text
Journal Article
Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis C Virus (HCV) Infection in Colombia
Garcia Marti, S, Alcaraz, A, Valanzasca, P, Garay, O.U, McMullen, M, Rey Ares, L, Idrovo, V, Prieto Ortiz, J, Tapias, M, Obregon, J, Ariza, J.G, Caporale, J
Published in Value in health (01.11.2013)
Published in Value in health (01.11.2013)
Get full text
Journal Article
PUK15 MEASURING THE ASSOCIATION OF SWITCHING PATIENTS FROM HEMODIALYSIS TO EXPANDED HEMODIALYSIS, WITH HOSPITALIZATIONS, MEDICATION USE, COSTS, AND PATIENT UTILITY
Ariza, J.G., Walton, S.M., Sanabria, M., Vesga, J., Suarez, A., Rivera, A.
Published in Value in health (01.05.2020)
Published in Value in health (01.05.2020)
Get full text
Journal Article
PUK14 COST-UTILITY ANALYSIS OF DIFFERENT DIALYSIS MODALITIES FOR TO TREAT END-STAGE RENAL DISEASE: A LATIN AMERICAN PERSPECTIVE
Ariza, J.G., Marasco, G., Pereira, A.C., Pepe, C., Ramirez Almazán, M.A., Jiménez Aranda, P., Gresse, S.
Published in Value in health (01.05.2020)
Published in Value in health (01.05.2020)
Get full text
Journal Article